Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.07

-0.5%

2:15 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robohogs who wrote (5517)	1/22/2002 1:00:13 PM
From: scott_jiminez	of 52153

I was encouraged by the original mouse data with AN-1792 (modified beta-amyloid 42 [i.e. Ab42]) and was looking forward to the PII results. The news release does indeed make it sound like there was a viral contamination...but there's always the possibility it's a lot more than that. In other words, a mouse vs. human dichotomy once again. I'm not sure what you mean by a 'fraction of the franchise' but if someone indeed nails the right pathway, agent etc. (amyloid, secretase, microglial products, cholinergic agents...), then they could 'get' the whole enchilada.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next